Table 3.
BED (n = 10) | No BED (n = 102) | ORB | p | |
---|---|---|---|---|
Age, (years) M (SD)A | 35.10 (13.21) | 42.48 (12.85) | 0.957 | 0.135 |
Gender, n (%) | 0.355C | |||
Female | 10 (100) | 85 (83.3) | ||
Ethnicity, n (%) | 0.996 | 0.993 | ||
White | 8 (80.0) | 91 (89.2) | ||
Recruitment site, n (%) | 0.532 | 0.407 | ||
Pittsburgh | 6 (60.0) | 42 (41.2) | ||
Bethesda | 4 (40.0) | 60 (58.8) | ||
Atypical symptom score, M (SD) | 14.30 (6.29) | 11.13 (3.96) | 1.166 | 0.102 |
Typical symptom score, M (SD) | 18.20 (6.44) | 17.34 (5.07) | 1.003 | 0.969 |
GSS, M (SD) | 18.00 (2.62) | 15.04 (4.09) | 1.246 | 0.097 |
Age data were missing for one participant in the No BED Group.
OR = odds ratio.
Given that there were no males in the SAD sample who met criteria for BED as defined by the DSM-IV-TR, a Fisher’s exact test was conducted to statistically estimate the effect of gender on the likelihood of having BED rather than logistic regression. No effect of gender was observed (χ2 (1, 112) = 1.965, p = 0.355, two-tailed Fisher’s Exact Test).